83 related articles for article (PubMed ID: 33926825)
1. Primary medication nonadherence calculation method specifications impact resulting rates.
Zuckerman AD; DeClercq J; Shah NB; Reynolds VW; Peter ME; Pavlik AM; Choi L
Res Social Adm Pharm; 2022 Mar; 18(3):2478-2483. PubMed ID: 33926825
[TBL] [Abstract][Full Text] [Related]
2. Primary medication nonadherence to oral oncology specialty medications.
Zuckerman AD; Shah NB; Perciavalle K; Looney B; Peter ME; DeClercq J; Moore R; Choi L; Reynolds VW
J Am Pharm Assoc (2003); 2022; 62(3):809-816.e1. PubMed ID: 35065885
[TBL] [Abstract][Full Text] [Related]
3. Low rates of primary medication nonadherence in patients prescribed oral oncology agents across health system specialty pharmacies.
Zuckerman A; Crumb J; Kandah HM; Platt T; Duckworth D; Lo K; Mitchell D; Diamantides E; Streck CM; DeClercq J; Choi L; Patel R
J Manag Care Spec Pharm; 2023 Jul; 29(7):740-748. PubMed ID: 37404071
[No Abstract] [Full Text] [Related]
4. Store and prescription characteristics associated with primary medication nonadherence.
Jackson TH; Bentley JP; McCaffrey DJ; Pace P; Holmes E; West-Strum D
J Manag Care Spec Pharm; 2014 Aug; 20(8):824-32. PubMed ID: 25062076
[TBL] [Abstract][Full Text] [Related]
5. A randomized telephone intervention trial to reduce primary medication nonadherence.
Fischer MA; Jones JB; Wright E; Van Loan RP; Xie J; Gallagher L; Wurst AM; Shrank WH
J Manag Care Spec Pharm; 2015 Feb; 21(2):124-31. PubMed ID: 25615001
[TBL] [Abstract][Full Text] [Related]
6. Primary medication nonadherence rates to specialty disease-modifying antirheumatic drugs for rheumatoid arthritis within a health system specialty pharmacy.
Petry L; Zuckerman AD; DeClercq J; Choi L; Lynch B; Saknini M
J Manag Care Spec Pharm; 2023 Jul; 29(7):732-739. PubMed ID: 37404072
[No Abstract] [Full Text] [Related]
7. Association Between Method of Prescribing and Primary Nonadherence to Dermatologic Medication in an Urban Hospital Population.
Adamson AS; Suarez EA; Gorman AR
JAMA Dermatol; 2017 Jan; 153(1):49-54. PubMed ID: 27784045
[TBL] [Abstract][Full Text] [Related]
8. Pharmacy-based interventions to reduce primary medication nonadherence to cardiovascular medications.
Fischer MA; Choudhry NK; Bykov K; Brill G; Bopp G; Wurst AM; Shrank WH
Med Care; 2014 Dec; 52(12):1050-4. PubMed ID: 25322157
[TBL] [Abstract][Full Text] [Related]
9. Analysis of naloxone access and primary medication nonadherence in a community pharmacy setting.
Connolly E; McCall KL; Couture S; Felton M; Piper BJ; Bratberg JP; Tu C
J Am Pharm Assoc (2003); 2022; 62(1):49-54. PubMed ID: 34736865
[TBL] [Abstract][Full Text] [Related]
10. Poverty, Transportation Access, and Medication Nonadherence.
Hensley C; Heaton PC; Kahn RS; Luder HR; Frede SM; Beck AF
Pediatrics; 2018 Apr; 141(4):. PubMed ID: 29610400
[TBL] [Abstract][Full Text] [Related]
11. Trouble getting started: predictors of primary medication nonadherence.
Fischer MA; Choudhry NK; Brill G; Avorn J; Schneeweiss S; Hutchins D; Liberman JN; Brennan TA; Shrank WH
Am J Med; 2011 Nov; 124(11):1081.e9-22. PubMed ID: 22017787
[TBL] [Abstract][Full Text] [Related]
12. Impact of a pharmacist-led, primary medication nonadherence intervention program on prescription fills in underserved patient populations.
Cason JB; Rein LJ; Atchley D; Fountain M; Hohmeier KC
J Am Pharm Assoc (2003); 2023; 63(4):1057-1063.e2. PubMed ID: 37024012
[TBL] [Abstract][Full Text] [Related]
13. Adherence to self-administered biologic disease-modifying antirheumatic drugs across health-system specialty pharmacies.
Zuckerman AD; DeClercq J; Choi L; Cowgill N; McCarthy K; Lounsbery B; Shah R; Kehasse A; Thomas KC; Sokos L; Stutsky M; Young J; Carter J; Lach M; Wise K; Thomas TT; Ortega M; Lee J; Lewis K; Dura J; Gazda NP; Gerzenshtein L; Canfield S
Am J Health Syst Pharm; 2021 Nov; 78(23):2142-2150. PubMed ID: 34407179
[TBL] [Abstract][Full Text] [Related]
14. Use of a national database as a tool to identify primary medication non-adherence: The Estonian ePrescription system.
Laius O; Pisarev H; Volmer D; Kõks S; Märtson A; Maasalu K
Res Social Adm Pharm; 2018 Aug; 14(8):776-783. PubMed ID: 29030133
[TBL] [Abstract][Full Text] [Related]
15. Comparison of time to treatment initiation of specialty medications between an integrated health system specialty pharmacy and external specialty pharmacies.
Russell M; McCoy H; Platt T; Zeltner M; Rhudy C
J Manag Care Spec Pharm; 2024 Apr; 30(4):352-362. PubMed ID: 38555622
[TBL] [Abstract][Full Text] [Related]
16. Time to Filling of New Prescriptions for Chronic Disease Medications Among a Cohort of Elderly Patients in the USA.
Franklin JM; Mahesri M; Krumme AA; Barberio J; Fischer MA; Brill G; McKay C; Black H; Choudhry NK
J Gen Intern Med; 2018 Nov; 33(11):1877-1884. PubMed ID: 30054889
[TBL] [Abstract][Full Text] [Related]
17. The epidemiology of prescriptions abandoned at the pharmacy.
Shrank WH; Choudhry NK; Fischer MA; Avorn J; Powell M; Schneeweiss S; Liberman JN; Dollear T; Brennan TA; Brookhart MA
Ann Intern Med; 2010 Nov; 153(10):633-40. PubMed ID: 21079218
[TBL] [Abstract][Full Text] [Related]
18. Comparison of rates of adherence to oral chemotherapy medications filled through an internal health-system specialty pharmacy vs external specialty pharmacies.
McCabe CC; Barbee MS; Watson ML; Billmeyer A; Lee CE; Rupji M; Chen Z; Haumschild R; El-Rayes B
Am J Health Syst Pharm; 2020 Jul; 77(14):1118-1127. PubMed ID: 32537656
[TBL] [Abstract][Full Text] [Related]
19. A Pilot Study Exploring the Impact of a Primary Medication Non-Adherence Intervention among Four Chronic Disease States in One Regional Division of a Large Community Pharmacy Chain.
Wilson DH; Rein LJ; Fountain M; Brookhart A; Atchley D; Hohmeier KC
Pharmacy (Basel); 2023 Jan; 11(1):. PubMed ID: 36649021
[TBL] [Abstract][Full Text] [Related]
20. Medication (re)fill adherence measures derived from pharmacy claims data in older Americans: a review of the literature.
Sattler EL; Lee JS; Perri M
Drugs Aging; 2013 Jun; 30(6):383-99. PubMed ID: 23553512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
